NOTE: Some of the documents on this web page have been provided by external sources and have been inserted, as received, in the language and format of record. |
CT-2023-007 (Apotex)
|
Apotex Inc. v Paladin Labs Inc. et al
|
|
Section(s):
|
s.103.1 - Leave to Make Application under Sections 75, 76, 77 or 79
|
Filed on:
|
2023-09-29
|
Status:
|
Withdrawn 2023-10-13
|
Applicant(s):
|
Apotex Inc.
|
Respondent(s):
|
Paladin Labs Inc.
Endo Pharmaceuticals Inc.
Takeda Canada Inc.
Takeda Pharmaceuticals U.S.A. Inc.
|
Case Documents |
Pleading(s) |
Decision(s) |
#
|
Title
|
Date
|
---|---|---|
13
|
2023-10-03
|
|
Notice pursuant to subsection 103.1(5) of the Competition Act
|
2023-10-05
|
|
|
|
|
Other(s) |
#
|
Title
|
Date
|
---|---|---|
2023-10-04
|
||
|
|
|